Becton, Dickinson and Co. BDX

Becton, Dickinson and Company (BD) es una empresa global de tecnología médica dedicada al desarrollo, fabricación y venta de una variedad de suministros médicos, dispositivos, equipos de laboratorio y productos de diagnóstico. La empresa opera a través de tres segmentos de negocio: BD Medical, BD Life Sciences y BD Interventional. El segmento de BD Medical produce una variedad de tecnologías y dispositivos médicos que se utilizan para mejorar la prestación de servicios de salud en diferentes entornos. BD Medical consta de diversas unidades de negocio, incluidas soluciones de administración de medicamentos, soluciones de gestión de medicamentos, cuidado de la diabetes y sistemas farmacéuticos. El segmento de BD Life Sciences ofrece productos para la recolección segura y el transporte de muestras de diagnóstico, así como instrumentos y sistemas de reactivos para detectar una variedad de enfermedades infecciosas, infecciones asociadas a la atención médica y cánceres. El segmento de BD Interventional proporciona productos especializados en vascular, urología, oncología y cirugía.

Con 6 acciones de BDX (USD 1.084,02) habrías recibido USD 25,20 en dividendos en los últimos 12 meses.

• Zacks Investment Research 2 oct

  Zacks Industry Outlook Highlights McKesson, Cardinal Health, Becton, Dickinson, Merit Medical Systems and ProDex

  The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, and technology adoption, with the global market expected to reach $318.77 billion by 2031. However, tariffs, commodity inflation, and policy-driven pricing changes present headwinds. Five key stocks—McKesson, Cardinal Health, Becton Dickinson, Merit Medical Systems, and ProDex—are highlighted as well-positioned to capitalize on favorable industry trends through 2026.

  

• GlobeNewswire Inc. 1 oct

  Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight

  The global liver cancer diagnostics market is projected to grow from USD 10.5 billion in 2025 to USD 19.8 billion by 2034, driven by rising hepatocellular carcinoma incidence, increasing chronic liver disease prevalence, and advances in diagnostic technologies including liquid biopsy, AI-assisted imaging, and blood-based biomarkers. North America leads the market with 41% share, while Asia-Pacific is expected to be the fastest-growing region.

  

• Zacks Investment Research 1 oct

  5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve

  The Medical-Dental Supplies industry is positioned for growth driven by specialty care, biologics, GLP-1 therapies, AI automation, and aging demographics. The global medical supplies market is expected to reach $318.77 billion by 2031 with a 10% CAGR. However, tariffs, commodity inflation, and pharmaceutical pricing changes remain headwinds. Key industry players show mixed near-term prospects with the industry trading at favorable valuations compared to broader markets.

  

• GlobeNewswire Inc. 4 sept

  Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share

  The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with 34% market share, while Asia Pacific is the fastest-growing region at 15.5% CAGR. Consumables dominate with 68% market share, and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, and laboratory automation.

  

• GlobeNewswire Inc. 1 sept

  Syringe Filling Machine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031), Syringe Filling Machine Market to Reach USD 2.99 Billion

  The global syringe filling machine market is projected to grow from USD 2.09 billion in 2026 to USD 2.99 billion by 2031 at a 7.41% CAGR. Growth is driven by rising demand for prefilled syringes, automated fill-finish lines for biologics, and regulatory focus on aseptic accuracy. Automated systems dominate with 63.92% market share, while servo-driven piston technology leads at 44.05%. Asia-Pacific emerges as the fastest-growing region at 10.72% CAGR, driven by biologics capacity expansion.